Lee is Chairman of the Division of Pulmonary and Critical Care at Washington University School of Medicine in St. Louis

Visit the news center

A pulmonologist specializes in the body’s response to a lung infection

Anna Rosengart

Janet S. Lee, MD, a distinguished scientist and scientist in pulmonary and critical care medicine, was selected to lead the Department of Pulmonary Medicine and Intensive Care In the Department of Medicine at Washington University School of Medicine in St. Louis. Her appointment is effective January 3.

Lee comes to Washington University from the University of Pittsburgh School of Medicine, where she is Professor of Medicine in the Division of Pulmonary Diseases, Allergy, and Critical Care and Chief of Acute Lung Injury at the University of Pittsburgh Medical Center.

Also the director of the Center of Excellence for Acute Lung Injury and the Principal Center for Pulmonary Research at the University of Pittsburgh, Lee cares for patients requiring intensive care as well as those with advanced lung disease, including acute and chronic respiratory failure. Her research focuses on the host response to acute lower respiratory tract infection and the molecular basis of the distinct host-pathogen interactions that lead to lung infection.

“Dr. Lee is exceptionally qualified to take on this new role,” he said. Victoria J. Fraser, MDAdolphus Busch Professor of Medicine and chair of the department of medicine at the University of Washington School of Medicine. “She has a proven track record of conducting basic and multiplex discovery research with longstanding National Institutes of Health (NIH) funding. We welcome her to the University of Washington and look forward to working with her to continue and build on the premiere status of the Department of Pulmonary and Critical Care Medicine.”

Lee is a principal investigator on grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NHLBI), including a grant focused on host protection against encoded proteases in acute lung injury, and another grant on host control mechanisms in lung infections. She also leads a grant focused on patient-directed research in acute lung injury and another on complement components and activity in patients with acute respiratory distress syndrome. She leads a resident training grant and is a project leader in a program project grant to investigate immunosuppression in acute lung injury.

Lee also works as a teacher and mentor and has trained more than 22 pre-doctoral and post-doctoral interns in her lab. She has held leadership positions in the American Thoracic Society and most recently served as Chair of the Membership Committee. She is an elected member of the American Society for Clinical Investigation and the American Physicians Association.

She received her BA from Johns Hopkins University and her medical degree from Georgetown University School of Medicine. She completed her residency at the University of Alabama, Birmingham, and fellowship in pulmonary and critical care medicine at the University of Washington, Seattle. She joined the faculty of the University of Pittsburgh School of Medicine in 2004.

Michael J. Holtzman, MD, who has led the division of pulmonary and critical care medicine since 1992, is stepping down from his leadership role but will continue his research program. Holtzmann, MD, Selma and Hermann Selden Professor of Medicine, focused on understanding antiviral immune responses as pathways to exacerbation of chronic lung disease and as targets for novel drug discovery in respiratory diseases. His research includes the development of small molecule drug compounds and biologics for airway diseases, including asthma, chronic obstructive pulmonary disease, and postviral lung diseases.

“The band has thrived under Dr. Holtzmann’s long-term guidance,” said Fraser. “Under his visionary leadership, the department has experienced remarkable growth in the scope and depth of its clinical programs and its research and teaching activities. It has a national reputation for basic research in acute and chronic lung diseases, clinical care, and education in multiple key areas. Throughout the COVID-19 pandemic, the department’s faculty and staff have provided “Exceptional clinical care and important research under very challenging circumstances. We are grateful to Dr. Holtzmann for his outstanding leadership and vision, and are fortunate that he continues his successful research here at the University of Washington.”

About the University of Washington School of Medicine

Washoe medicine It is a global leader in academic medicine, including biomedical research, patient care, and educational programs with 2,700 faculty members. The National Institutes of Health’s (NIH) research funding portfolio is the fourth largest among U.S. medical schools, and has grown 54% in the past five years. Combined with institutional investment, WashU Medicine commits over $1 billion annually to basic research, clinical innovation, and training. . Its faculty practice is consistently in the top five in the country, with more than 1,790 faculty physicians practicing at more than 60 locations and they are also the medical staff at Barnes is Jewish And the Saint Louis Kids Hospitals BJC HealthCare. WashU Medicine has a strong history of MD/PhD training, recently committed $100 million to scholarships and curriculum renewals for medical students, and is home to first-class training programs in every medical subspecialty as well as physical therapy, occupational therapy, audiology, and communication sciences.

Leave a Comment